<?xml version='1.0' encoding='utf-8'?>
<document id="29784014"><sentence text="Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report."><entity charOffset="14-26" id="DDI-PubMed.29784014.s1.e0" text="sulfonylurea" /></sentence><sentence text="Sulfonylureas are widely used for type 2 diabetes mellitus, but these medications carry a risk of hypoglycemia"><entity charOffset="0-13" id="DDI-PubMed.29784014.s2.e0" text="Sulfonylureas" /></sentence><sentence text=" Drug-drug interactions that inhibit sulfonylurea metabolism and thus increase systemic exposure can cause unintentional sulfonylurea toxicity"><entity charOffset="37-49" id="DDI-PubMed.29784014.s3.e0" text="sulfonylurea" /><entity charOffset="121-133" id="DDI-PubMed.29784014.s3.e1" text="sulfonylurea" /><pair ddi="false" e1="DDI-PubMed.29784014.s3.e0" e2="DDI-PubMed.29784014.s3.e0" /><pair ddi="false" e1="DDI-PubMed.29784014.s3.e0" e2="DDI-PubMed.29784014.s3.e1" /></sentence><sentence text="" /><sentence text="A 56-year-old man presented with severe, recurrent hypoglycemia" /><sentence text=" He had a history of type 2 diabetes mellitus and was taking the sulfonylurea gliclazide with no prior episodes of hypoglycemia"><entity charOffset="65-88" id="DDI-PubMed.29784014.s6.e0" text="sulfonylurea gliclazide" /></sentence><sentence text=" The onset of his hypoglycemia occurred within days after starting voriconazole and subsequently fluconazole for a fungal pneumonia"><entity charOffset="67-79" id="DDI-PubMed.29784014.s7.e0" text="voriconazole" /><entity charOffset="97-108" id="DDI-PubMed.29784014.s7.e1" text="fluconazole" /><pair ddi="false" e1="DDI-PubMed.29784014.s7.e0" e2="DDI-PubMed.29784014.s7.e0" /><pair ddi="false" e1="DDI-PubMed.29784014.s7.e0" e2="DDI-PubMed.29784014.s7.e1" /></sentence><sentence text=" Unintentional sulfonylurea toxicity developed due to an adverse drug-drug interaction between gliclazide and these antifungals"><entity charOffset="15-27" id="DDI-PubMed.29784014.s8.e0" text="sulfonylurea" /><entity charOffset="95-105" id="DDI-PubMed.29784014.s8.e1" text="gliclazide" /><pair ddi="false" e1="DDI-PubMed.29784014.s8.e0" e2="DDI-PubMed.29784014.s8.e0" /><pair ddi="true" e1="DDI-PubMed.29784014.s8.e0" e2="DDI-PubMed.29784014.s8.e1" /></sentence><sentence text=" Azole antifungals inhibit the metabolism of sulfonylureas resulting in increased systemic exposure and consequent toxicity"><entity charOffset="1-6" id="DDI-PubMed.29784014.s9.e0" text="Azole" /><entity charOffset="45-58" id="DDI-PubMed.29784014.s9.e1" text="sulfonylureas" /><pair ddi="false" e1="DDI-PubMed.29784014.s9.e0" e2="DDI-PubMed.29784014.s9.e0" /><pair ddi="false" e1="DDI-PubMed.29784014.s9.e0" e2="DDI-PubMed.29784014.s9.e1" /></sentence><sentence text=" After the diagnosis of sulfonylurea toxicity was recognized, the patient was treated initially with dextrose and then administered octreotide to prevent recurrent hypoglycemia"><entity charOffset="24-36" id="DDI-PubMed.29784014.s10.e0" text="sulfonylurea" /><entity charOffset="101-109" id="DDI-PubMed.29784014.s10.e1" text="dextrose" /><entity charOffset="132-142" id="DDI-PubMed.29784014.s10.e2" text="octreotide" /><pair ddi="false" e1="DDI-PubMed.29784014.s10.e0" e2="DDI-PubMed.29784014.s10.e0" /><pair ddi="false" e1="DDI-PubMed.29784014.s10.e0" e2="DDI-PubMed.29784014.s10.e1" /><pair ddi="false" e1="DDI-PubMed.29784014.s10.e0" e2="DDI-PubMed.29784014.s10.e2" /><pair ddi="false" e1="DDI-PubMed.29784014.s10.e1" e2="DDI-PubMed.29784014.s10.e1" /><pair ddi="false" e1="DDI-PubMed.29784014.s10.e1" e2="DDI-PubMed.29784014.s10.e2" /></sentence><sentence text=" He was successfully managed, his hypoglycemic episodes resolved, and his medications were adjusted to avoid any further adverse interactions" /><sentence text="" /><sentence text="Adverse drug-drug interactions continue to pose challenges to clinicians" /><sentence text=" Both individual vigilance and system wide strategies are needed to prevent and mitigate consequences" /><sentence text=" This case highlights an important drug-drug interaction and reviews the presentation, management and antidotal therapy of sulfonylurea toxicity"><entity charOffset="123-135" id="DDI-PubMed.29784014.s15.e0" text="sulfonylurea" /></sentence><sentence text="" /></document>